Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
7(58%)
Results Posted
200%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
4
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

7

trials recruiting

Total Trials

12

all time

Status Distribution
Active(7)
Completed(1)
Terminated(2)
Other(2)

Detailed Status

Active, not recruiting4
Recruiting3
unknown2
Completed1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
7
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting325%
completed18%
unknown217%
terminated18%
withdrawn18%
active_not_recruiting433%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12